You have 9 free searches left this month | for more free features.

City

Condition

Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Qilu Pharmaceutical Co., Ltd. (1)

Collaborator

Intervention

ql1706 (1)

tilesizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

tilesizumab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Lung Cancer Trial (QL1706, Tilesizumab)

Not yet recruiting

Lung Cancer

QL1706
Tilesizumab

(no location specified)

Jan 10, 2023